Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. News
  3. Accueil
  4. Business Leaders Biography

Business Leaders
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Michele Alberto Fabiano Crisostomo

Michele Alberto Fabiano Crisostomo
Age : 49
Country of residence : Unknown
Linked companies : Enel SpA

Biography of Michele Alberto Fabiano Crisostomo 
Currently, Michele Alberto Fabiano Crisostomo is Chairman for Enel SpA. In her past career she was Partner at Clifford Chance Studio Legale Associato. She received a graduate degree from the University of Bari.


Current positions of Michele Alberto Fabiano Crisostomo 
NameTitle Since
Enel SpA
(Electric Utilities)		 Chairman 2020


Michele Alberto Fabiano Crisostomo : Personal Network 


Most Read News 
06/04JACK DORSEY : Square considering making bitcoin hardware wallet -Dorsey
RE
06/01LEON BLACK : Woman's lawsuit accuses Leon Black of defamation, violent behavior
RE
06/07JEFF BEZOS : Amazon's billionaire founder Jeff Bezos to fly to space next month
RE
06/02BILL GATES : Bill Gates' next generation nuclear reactor to be built in Wyoming
RE
06/08CHAMATH PALIHAPITIYA : Palihapitiya's $16 million bet on Clover worth $682 million on Reddit rally
RE
05/31ELON MUSK : Tesla's vehicle price increases due to supply chain pressure, Musk says
RE
01:22pJEFF BEZOS : Bid of $28 million wins a rocket trip to space with Bezos
RE
06/04WILLIAM ACKMAN : Ackman reinvents SPAC in Universal Music deal talks
RE
06/01TERRY GOU : Foxconn, founder Gou apply to purchase BioNTech vaccines for Taiwan
RE
06/11ELON MUSK : 'This car crushes' Musk says, as Tesla launches faster Model S 'Plaid'
RE
More news


© 2021 People and Ownership :   
Michele Alberto Fabiano Crisostomo : Connections 


Latest news about Michele Alberto Fabiano Crisostomo 
06/11U.S. FDA faces mounting criticism over Alzheimer's drug approval
RE
06/11ENI  : Receives a Buy rating from Goldman Sachs
MD
06/11BP  : Receives a Buy rating from Goldman Sachs
MD
06/11SHELL A  : Goldman Sachs maintains a Buy rating
MD
06/10EXCLUSIVE : Eli Lilly memo says firm did not make false statements to FDA
RE
More news